CHU-128 is an effective and selective GLP-1R agonist. CHU-128 exhibits strong signal specificity and can activate the Gs/cAMP pathway, but it cannot activate the Gq/calcium signal, ERK phosphorylation, or recruit beta-inhibitory proteins. CHU-128 can be used for research on type 2 diabetes[1][2].
Molekulargewicht:
883.94
CAS Nummer:
[2212020-93-2]
Formel:
C47H47F2N11O5
Target-Kategorie:
GLP Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
